Cosmos Pharmaceutical Corporation announced that consolidated operating profit for the six months ending November 2026 is expected to be ¥20.7 billion. The official announcement indicates this forecast profit.
COSMOS Pharmaceutical Corporation announced on the 13th that consolidated operating profit for the June-November 2026 period is expected to be ¥20.7 billion in the black.
The announcement was reported as the latest disclosure concerning the company's earnings outlook for the period.